IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL

Dustin Andersen Patel, Trine Alma Knudsen, Dennis Lund Hansen, Lucas Frans Ocias, Ole Weiss Bjerrum, Mette Brabrand, Christina Ellervik, Daniel el Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben Kruse, Hans Torben Mourits-Andersen, Peter Møller, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Anders Lindholm Sørensen, Stentoft Jesper, Jørn StarklintKarin de Stricker, Mads Thomassen, Thomas Stauffer Larsen, Hans Carl Hasselbalch

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Cite this

Andersen Patel, D., Knudsen, T. A., Lund Hansen, D., Ocias, L. F., Weiss Bjerrum, O., Brabrand, M., Ellervik, C., el Fassi, D., Frederiksen, M., Kjær, L., Kielsgaard Kristensen, T., Kruse, T., Mourits-Andersen, H. T., Møller, P., Overgaard, U. M., Severinsen, M. T., Skov, V., Lindholm Sørensen, A., Jesper, S., ... Hasselbalch, H. C. (2019). IMPACT OF SMOKING ON JAK2V617F ALLELE BURDEN AMONG PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS TREATED WITH PEGYLATED INTERFERON ALPHA-2 OR HYDROXYUREA IN THE DALIAH TRIAL. HemaSphere, 2019, [PB2210].